Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?-Reference-Cited by-同舟云学术

Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

Published:2017-02-23 Issue:1 Volume:17 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Luo Yanji,Chen Jie,Huang Kun,Lin Yuan,Chen Minhu,Xu Ling,Li Zi-Ping,Feng Shi-Ting

Funder

National Natural Science Foundation ofChina (CN)

Natural Science Foundation of Guangdong Province

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3150-7.pdf

Reference31 articles.

1. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.

2. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.

3. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–59.

4. Klöppel G. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer. 2011;18 Suppl 1:S1–16.

5. de Mestier L, Lardière-Deguelte S, Brixi H, O'Toole D, Ruszniewski P, Cadiot G, et al. Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors. Neuroendocrinology. 2015;101:105–11.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cylindrical TGR as early radiological predictor of RLT progression in GEPNETs: a proof of concept;Scientific Reports;2024-07-09

2. Appendiceal Neuroendocrine Neoplasms: A Comprehensive Review;Journal of Computer Assisted Tomography;2023-08-11

3. Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST;Journal of Neuroendocrinology;2023-06

4. Neuroendocrine Tumor Therapy Response Assessment;PET Clinics;2023-04

5. PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score;Life;2023-02-22